Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. BLSM

Market Cap: $606.63M

BI

BlossomHill Therapeutics, Inc.

BLSM
NASDAQUSD
Purchase BLSM
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Executive

Jingrong Jean Cui

Scientific Founder, President, CEO & Director

Compensation
$763,947
Li Yishan

Co-Founder & Executive Chairman

Compensation
$574,000
Vincent Liptak

General Counsel & Executive VP

Compensation
Compensation not disclosed
Antonio Garrido-Montalban

Senior Vice President of Drug Substance

Compensation
Compensation not disclosed
Eugene Y. Rui

Senior Vice President of Chemistry

Compensation
Compensation not disclosed
Z. Jesse Shao

Senior Vice President of CMC

Compensation
Compensation not disclosed
Zachary F. Zimmerman

Senior Vice President of Clinical Development

Compensation
Compensation not disclosed
Ashley Preston

Senior VP and Head of Regulatory Affairs & Quality Assurance

Compensation
Compensation not disclosed
Geoff Oxnard

Chief Medical Officer & Executive VP

Compensation
$797,000
Jason A. Keyes

CFO & Executive VP

Compensation
$464,746